May 2, 2013
Jefferson City, Mo. -- Attorney General Chris Koster announced today that $603,493 has been recovered for the Missouri Medicaid program as part of a national settlement against the drug manufacturer Amgen, Inc. The parties settled the case to resolve allegations that Amgen violated federal and state law, including the Federal False Claims Act, the Federal Anti-Kickback Statute, and certain states' false claims acts, with respect to the marketing of Aranesp, a prescription drug manufactured by the company for the treatment of anemia.
Missouri, along with the federal government and several other states, alleged that Amgen agreed to provide certain institutional pharmacies additional rebates on Aranesp in exchange for the promise that these pharmacies would promote the drug in nursing homes they served. The alleged purpose of the scheme was to induce medical professionals working at these facilities to dispense Aranesp in place of competing drugs.
"Pharmaceutical companies must play by the rules or be held accountable for their actions," Koster said. "My office will continue to fight Medicaid fraud and return these scarce health-care dollars to the state," Koster said.